US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

108.27

-0.1300-0.12%

Volume:254.31K

Turnover:27.52M

Market Cap:4.92B

PE:52.81

High:108.67

Open:108.13

Low:106.84

Close:108.40

52wk High:109.57

52wk Low:47.32

Shares:45.45M

Float Shares:44.60M

Volume Ratio:0.23

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.05

EPS(LYR):2.05

ROE:11.20%

ROA:6.60%

PB:5.88

PE(LYR):52.81

Loading ...

Overview Company News Filings

Here's one reason why experts think the CSL share price can rise 65%!

Press Release: KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology

Is New HAE Patient-Reported Outcome Study Altering The Investment Case For Pharvaris’ Deucrictibant (PHVS)?

Simply Wall St.

Takeda’s New South Korea HAE Study Aims to Cement Takhzyro’s Real World Edge

Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside

Early Outperformance and Expanding On‑Demand HAE Opportunity Justify Buy Rating on KalVista

Haemonetics Is Maintained at Neutral by Citigroup

Pharvaris reports results from study of patient experience during HAE attacks

Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology

Haemonetics price target lowered to $70 from $75 at Citi

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

Haemonetics Wins FDA Nod For Persona PLUS Plasma Growth Opportunity

Simply Wall St.

BRIEF-Haemonetics Corp - Repays Outstanding 0.00% Convertible Senior Notes - SEC Filing

Haemonetics Corp - Repayment Funded With Cash and Credit Facility Borrowings - SEC Filing

THOMSON REUTERS

Haemonetics Corp - Pays $300 Mln for Outstanding Notes - SEC Filing

THOMSON REUTERS

Haemonetics Repays $300 Million Convertible Notes at Maturity

Assessing Haemonetics (HAE) Valuation After FDA Clearance Of NexSys PCS Persona PLUS System

Simply Wall St.

Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026

BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/HAE/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HAE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HAE\",,,,,undefined,":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"Haemonetics","latestPrice":108.27,"timestamp":1787686908079,"preClose":108.4,"halted":0,"volume":254305,"delay":0,"changeRate":-0.0011992619926200153,"floatShares":44597205,"shares":45446000,"eps":2.05,"marketStatus":"Trading","change":-0.13,"latestTime":"08-25 15:41:53 EDT","open":108.13,"high":108.67,"low":106.8391,"amount":27515686.56275,"amplitude":0.01689,"askPrice":108.27,"askSize":268,"bidPrice":108.11,"bidSize":120,"shortable":3,"etf":0,"ttmEps":2.05,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":673761600000,"exchange":"NYSE","adjPreClose":108.4,"preHourTrading":{"tag":"盘前","latestPrice":107.71,"preClose":108.4,"latestTime":"09:19 EDT","volume":111,"amount":11932.76973,"timestamp":1787663999331,"change":-0.69,"changeRate":-0.006365,"amplitude":0.021956},"postHourTrading":{"tag":"盘后","latestPrice":108.4,"preClose":108.4,"latestTime":"19:30 EDT","volume":22915,"amount":2483982.37,"timestamp":1787614205861,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.226704,"impliedVol":0.3636,"impliedVolPercentile":0.1793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HAE\",,,,,undefined,":{"symbol":"HAE","floatShares":44597205,"roa":"6.60%","roe":"11.20%","lyrEps":2.05,"volumeRatio":0.226704,"shares":45446000,"dividePrice":0,"high":108.67,"amplitude":0.01689,"preClose":108.4,"low":106.8391,"week52Low":47.315,"pbRate":"5.88","psRate":"3.64","week52High":109.5707,"institutionHeld":0.7998,"latestPrice":108.27,"committee":-0.381443,"eps":2.05,"divideRate":0,"volume":254305,"delay":0,"ttmEps":2.05,"open":108.13,"prevYearClose":80.15,"prevWeekClose":108.8,"prevMonthClose":85.54,"prevQuarterClose":75,"fiveDayClose":104.65,"twentyDayClose":82.54,"sixtyDayClose":67.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HAE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"HAE","fiscalQuarterEnding":"2026/06","expectedEps":1.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":1.14},{"market":"US","date":"2026-05-07","symbol":"HAE","fiscalQuarterEnding":"2026/03","expectedEps":1.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":1.29},{"market":"US","date":"2026-02-05","symbol":"HAE","fiscalQuarterEnding":"2025/12","expectedEps":1.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770267600000,"reportTimeType":"pre","actualEps":1.19},{"market":"US","date":"2025-11-06","symbol":"HAE","fiscalQuarterEnding":"2025/09","expectedEps":1.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":1.27},{"market":"US","date":"2025-08-07","symbol":"HAE","fiscalQuarterEnding":"2025/06","expectedEps":1.01,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":1.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HAE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HAE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.3636,"hold":0.2727,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1779681600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HAE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HAE","date":"2026-08-24","current":52.814634,"percent":0.755501,"low":13.951789,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"high":144.446304,"avg":43.357536,"sd":26.885345,"marketCap":4950079148},"quantilePoints":[{"date":"2021-08-27","current":48.594678,"twenty":-35.993895,"median":65.007443,"eighty":109.700335,"marketCap":3133773592},{"date":"2021-09-03","current":51.028758,"twenty":-35.993895,"median":64.365454,"eighty":109.700335,"marketCap":3290742574},{"date":"2021-09-10","current":53.320587,"twenty":-35.993895,"median":63.662493,"eighty":109.700335,"marketCap":3438538043},{"date":"2021-09-17","current":55.493874,"twenty":-35.993895,"median":63.358892,"eighty":109.700335,"marketCap":3578688920},{"date":"2021-09-24","current":54.916965,"twenty":-35.993895,"median":63.068193,"eighty":109.700335,"marketCap":3541485232},{"date":"2021-10-01","current":56.900582,"twenty":-35.993895,"median":62.475524,"eighty":109.700335,"marketCap":3669404760},{"date":"2021-10-08","current":53.344296,"twenty":-35.993895,"median":61.853028,"eighty":109.700335,"marketCap":3440066962},{"date":"2021-10-15","current":55.248885,"twenty":-35.993895,"median":61.375039,"eighty":109.700335,"marketCap":3562890094},{"date":"2021-10-22","current":56.703011,"twenty":-35.993895,"median":61.047856,"eighty":109.700335,"marketCap":3656663771},{"date":"2021-10-29","current":54.300542,"twenty":-35.993895,"median":60.807745,"eighty":109.700335,"marketCap":3501733348},{"date":"2021-11-05","current":58.947423,"twenty":-35.993895,"median":60.537162,"eighty":109.700335,"marketCap":3801401403},{"date":"2021-11-12","current":98.0786,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":3064269710},{"date":"2021-11-19","current":91.879169,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2870580881},{"date":"2021-11-26","current":84.9273,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2653383645},{"date":"2021-12-03","current":86.317674,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2696823092},{"date":"2021-12-10","current":84.812799,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2649806279},{"date":"2021-12-17","current":86.890181,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2714709923},{"date":"2021-12-23","current":88.591344,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2767859365},{"date":"2021-12-31","current":86.759322,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2710621505},{"date":"2022-01-07","current":86.088671,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2689668360},{"date":"2022-01-14","current":86.186815,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2692734674},{"date":"2022-01-21","current":80.249102,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2507222681},{"date":"2022-01-28","current":75.178327,"twenty":-35.965051,"median":60.537162,"eighty":109.693612,"marketCap":2348796462},{"date":"2022-02-04","current":76.241554,"twenty":-35.965051,"median":60.537162,"eighty":109.693612,"marketCap":2382014863},{"date":"2022-02-11","current":132.27526,"twenty":-34.668681,"median":60.807745,"eighty":111.039755,"marketCap":2988494959},{"date":"2022-02-18","current":125.601547,"twenty":-34.469979,"median":61.047856,"eighty":111.532645,"marketCap":2837715754},{"date":"2022-02-25","current":129.379548,"twenty":-34.311338,"median":61.359457,"eighty":111.98412,"marketCap":2923072118},{"date":"2022-03-04","current":132.003787,"twenty":-34.051744,"median":61.783676,"eighty":112.835267,"marketCap":2982361568},{"date":"2022-03-11","current":121.778301,"twenty":-33.85785,"median":62.188491,"eighty":113.319081,"marketCap":2751337158},{"date":"2022-03-18","current":129.583152,"twenty":-33.51653,"median":62.994775,"eighty":114.080433,"marketCap":2927672161},{"date":"2022-03-25","current":134.4018,"twenty":-33.327443,"median":63.351243,"eighty":114.297089,"marketCap":3036539858},{"date":"2022-04-01","current":144.446304,"twenty":12.858807,"median":63.591935,"eighty":114.85374,"marketCap":3263475340},{"date":"2022-04-08","current":135.329333,"twenty":26.526131,"median":64.365454,"eighty":118.412035,"marketCap":3057495612},{"date":"2022-04-14","current":128.542506,"twenty":27.793219,"median":64.890745,"eighty":123.456909,"marketCap":2904160827},{"date":"2022-04-22","current":122.185511,"twenty":29.124226,"median":65.319181,"eighty":124.18094,"marketCap":2760537245},{"date":"2022-04-29","current":114.62951,"twenty":31.542784,"median":65.565922,"eighty":124.252941,"marketCap":2589824518},{"date":"2022-05-06","current":117.366864,"twenty":32.033452,"median":67.0792,"eighty":124.252941,"marketCap":2651669548},{"date":"2022-05-13","current":66.271265,"twenty":35.464129,"median":67.3946,"eighty":124.252941,"marketCap":2874516102},{"date":"2022-05-20","current":69.90063,"twenty":36.481486,"median":68.104166,"eighty":124.252941,"marketCap":3031939815},{"date":"2022-05-27","current":75.603918,"twenty":37.198319,"median":69.227072,"eighty":124.252941,"marketCap":3279319935},{"date":"2022-06-03","current":76.004562,"twenty":37.61535,"median":69.681162,"eighty":124.252941,"marketCap":3296697877},{"date":"2022-06-10","current":76.26261,"twenty":38.029161,"median":70.362161,"eighty":124.252941,"marketCap":3307890688},{"date":"2022-06-17","current":71.841246,"twenty":38.485794,"median":71.159351,"eighty":124.252941,"marketCap":3116114046},{"date":"2022-06-24","current":77.149247,"twenty":38.879824,"median":71.841246,"eighty":124.324942,"marketCap":3346348571},{"date":"2022-07-01","current":79.584543,"twenty":39.929153,"median":72.054039,"eighty":124.324942,"marketCap":3451979555},{"date":"2022-07-08","current":78.969808,"twenty":40.349299,"median":72.422071,"eighty":124.324942,"marketCap":3425315423},{"date":"2022-07-15","current":75.798905,"twenty":40.806308,"median":73.633206,"eighty":124.324942,"marketCap":3287777520},{"date":"2022-07-22","current":78.187949,"twenty":41.868556,"median":74.543389,"eighty":124.324942,"marketCap":3391402276},{"date":"2022-07-29","current":82.185457,"twenty":42.602719,"median":74.985852,"eighty":124.324942,"marketCap":3564794194},{"date":"2022-08-05","current":82.291899,"twenty":43.849716,"median":75.3419,"eighty":124.324942,"marketCap":3569411138},{"date":"2022-08-12","current":56.977427,"twenty":44.747815,"median":75.512988,"eighty":124.324942,"marketCap":3857713676},{"date":"2022-08-19","current":57.936321,"twenty":45.53495,"median":75.512988,"eighty":124.324942,"marketCap":3922636546},{"date":"2022-08-26","current":56.94343,"twenty":46.060774,"median":75.512988,"eighty":124.324942,"marketCap":3855411875},{"date":"2022-09-02","current":55.889905,"twenty":46.344767,"median":75.512988,"eighty":124.324942,"marketCap":3784081880},{"date":"2022-09-09","current":58.262232,"twenty":46.74555,"median":75.512988,"eighty":124.324942,"marketCap":3944702660},{"date":"2022-09-16","current":58.186439,"twenty":47.088487,"median":75.512988,"eighty":124.324942,"marketCap":3939571006},{"date":"2022-09-23","current":55.889905,"twenty":47.296251,"median":75.512988,"eighty":124.324942,"marketCap":3784081880},{"date":"2022-09-30","current":56.109705,"twenty":47.555234,"median":75.512988,"eighty":124.324942,"marketCap":3798963678},{"date":"2022-10-07","current":57.557355,"twenty":48.010942,"median":75.512988,"eighty":124.324942,"marketCap":3896978275},{"date":"2022-10-14","current":58.012114,"twenty":48.76538,"median":75.512988,"eighty":124.324942,"marketCap":3927768201},{"date":"2022-10-21","current":60.649717,"twenty":49.274711,"median":75.512988,"eighty":124.324942,"marketCap":4106349770},{"date":"2022-10-28","current":63.272162,"twenty":49.733238,"median":75.512988,"eighty":124.324942,"marketCap":4283905009},{"date":"2022-11-04","current":61.134794,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4139192358},{"date":"2022-11-11","current":46.610721,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4010712688},{"date":"2022-11-18","current":47.010661,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4045126374},{"date":"2022-11-25","current":49.145638,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4228834728},{"date":"2022-12-02","current":50.66306,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4359404302},{"date":"2022-12-09","current":47.134172,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4055754130},{"date":"2022-12-16","current":46.069625,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":3964152995},{"date":"2022-12-23","current":46.56955,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4007170103},{"date":"2022-12-30","current":46.257832,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":3980347671},{"date":"2023-01-06","current":43.287685,"twenty":50.066658,"median":75.178327,"eighty":123.589501,"marketCap":3724775443},{"date":"2023-01-13","current":50.410156,"twenty":49.925919,"median":74.62356,"eighty":121.823547,"marketCap":4337642707},{"date":"2023-01-20","current":52.53337,"twenty":49.925919,"median":74.252899,"eighty":117.448306,"marketCap":4520338893},{"date":"2023-01-27","current":50.098438,"twenty":49.925919,"median":73.400375,"eighty":115.406743,"marketCap":4310820275},{"date":"2023-02-03","current":51.245326,"twenty":49.800935,"median":72.34781,"eighty":114.777933,"marketCap":4409506581},{"date":"2023-02-10","current":42.450958,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4065061322},{"date":"2023-02-17","current":42.819731,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4100374588},{"date":"2023-02-24","current":41.565905,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3980309485},{"date":"2023-03-03","current":41.091769,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3934906716},{"date":"2023-03-10","current":39.695703,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3801220782},{"date":"2023-03-17","current":40.359493,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3864784660},{"date":"2023-03-24","current":40.786215,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3905647153},{"date":"2023-03-31","current":43.594152,"twenty":49.766923,"median":72.183716,"eighty":114.652068,"marketCap":4174532445},{"date":"2023-04-06","current":44.431792,"twenty":49.766923,"median":72.183716,"eighty":114.652068,"marketCap":4254744005},{"date":"2023-04-14","current":45.048169,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4313767606},{"date":"2023-04-21","current":44.268479,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4239105273},{"date":"2023-04-28","current":43.615225,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4176550346},{"date":"2023-05-05","current":42.587931,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4078177678},{"date":"2023-05-12","current":37.524937,"twenty":49.634964,"median":72.006752,"eighty":114.674627,"marketCap":4330415288},{"date":"2023-05-19","current":36.432063,"twenty":49.470785,"median":71.609259,"eighty":114.674627,"marketCap":4204296483},{"date":"2023-05-26","current":36.297944,"twenty":49.138253,"median":70.90224,"eighty":114.674627,"marketCap":4188819017},{"date":"2023-06-02","current":37.914008,"twenty":48.900494,"median":70.079794,"eighty":114.674627,"marketCap":4375314458},{"date":"2023-06-09","current":38.684814,"twenty":48.81157,"median":69.523462,"eighty":114.697185,"marketCap":4464266214},{"date":"2023-06-16","current":36.5432,"twenty":48.359383,"median":68.782359,"eighty":114.697185,"marketCap":4217121848},{"date":"2023-06-23","current":37.41357,"twenty":48.034039,"median":67.855084,"eighty":114.719744,"marketCap":4317563349},{"date":"2023-06-30","current":37.198726,"twenty":47.795111,"median":67.0792,"eighty":114.742302,"marketCap":4292770122},{"date":"2023-07-07","current":36.199043,"twenty":47.513839,"median":65.87122,"eighty":114.742302,"marketCap":4177405720},{"date":"2023-07-14","current":37.571414,"twenty":47.13704,"median":65.431477,"eighty":114.742302,"marketCap":4335778781},{"date":"2023-07-21","current":40.517848,"twenty":47.09989,"median":65.085875,"eighty":114.742302,"marketCap":4675800177},{"date":"2023-07-28","current":40.991382,"twenty":46.893622,"median":64.463228,"eighty":114.62951,"marketCap":4730446472},{"date":"2023-08-04","current":40.180236,"twenty":46.640128,"median":63.848761,"eighty":114.62951,"marketCap":4636839392},{"date":"2023-08-11","current":33.780528,"twenty":46.453003,"median":63.523476,"eighty":114.197827,"marketCap":4613271549},{"date":"2023-08-18","current":32.135505,"twenty":46.303836,"median":63.329166,"eighty":113.741296,"marketCap":4388617345},{"date":"2023-08-25","current":32.090944,"twenty":46.104914,"median":62.994775,"eighty":112.790968,"marketCap":4382531904},{"date":"2023-09-01","current":33.32007,"twenty":45.899062,"median":62.338276,"eighty":111.980393,"marketCap":4550388657},{"date":"2023-09-08","current":32.644236,"twenty":45.588443,"median":61.963237,"eighty":111.151185,"marketCap":4458092799},{"date":"2023-09-15","current":33.442611,"twenty":45.332649,"median":61.591282,"eighty":108.66356,"marketCap":4567123620},{"date":"2023-09-22","current":33.453751,"twenty":45.027096,"median":61.359457,"eighty":104.4523,"marketCap":4568644980},{"date":"2023-09-29","current":33.851082,"twenty":44.674128,"median":61.088808,"eighty":100.62634,"marketCap":4622906831},{"date":"2023-10-06","current":32.506842,"twenty":44.409226,"median":60.907196,"eighty":99.38139,"marketCap":4439329355},{"date":"2023-10-13","current":32.562542,"twenty":44.268479,"median":60.628899,"eighty":98.805587,"marketCap":4446936156},{"date":"2023-10-20","current":33.568866,"twenty":43.94712,"median":60.337322,"eighty":98.141199,"marketCap":4584365704},{"date":"2023-10-27","current":31.025207,"twenty":43.721642,"median":60.270751,"eighty":97.618547,"marketCap":4236988435},{"date":"2023-11-03","current":33.805375,"twenty":43.615225,"median":59.995745,"eighty":97.24472,"marketCap":4336452084},{"date":"2023-11-10","current":33.852843,"twenty":43.397999,"median":59.590266,"eighty":96.788062,"marketCap":4342541181},{"date":"2023-11-17","current":35.292717,"twenty":43.09473,"median":59.300599,"eighty":96.510871,"marketCap":4527243797},{"date":"2023-11-24","current":32.41297,"twenty":42.882949,"median":59.047612,"eighty":96.179039,"marketCap":4157838565},{"date":"2023-12-01","current":31.989711,"twenty":42.721248,"median":58.920552,"eighty":96.025608,"marketCap":4103544114},{"date":"2023-12-08","current":32.935122,"twenty":42.386415,"median":58.853577,"eighty":95.310906,"marketCap":4224818635},{"date":"2023-12-15","current":35.110755,"twenty":42.308016,"median":58.70523,"eighty":94.9012,"marketCap":4503902258},{"date":"2023-12-22","current":33.821198,"twenty":41.984872,"median":58.322866,"eighty":94.533572,"marketCap":4338481783},{"date":"2023-12-29","current":34.378951,"twenty":41.734279,"median":58.224335,"eighty":94.358582,"marketCap":4410028676},{"date":"2024-01-05","current":32.361546,"twenty":41.565905,"median":58.012114,"eighty":94.027739,"marketCap":4151242043},{"date":"2024-01-12","current":32.765027,"twenty":41.050004,"median":57.901951,"eighty":93.689799,"marketCap":4202999369},{"date":"2024-01-19","current":33.030059,"twenty":40.916657,"median":57.809931,"eighty":92.879374,"marketCap":4236996829},{"date":"2024-01-26","current":32.132116,"twenty":40.786215,"median":57.557355,"eighty":92.217147,"marketCap":4121811406},{"date":"2024-02-02","current":30.854426,"twenty":40.645981,"median":57.415067,"eighty":91.542793,"marketCap":3957913206},{"date":"2024-02-09","current":31.340588,"twenty":40.530546,"median":57.27692,"eighty":90.845062,"marketCap":3966903598},{"date":"2024-02-16","current":28.840884,"twenty":40.391805,"median":57.021432,"eighty":90.511809,"marketCap":3650506089},{"date":"2024-02-23","current":30.052619,"twenty":40.28554,"median":56.959244,"eighty":90.267746,"marketCap":3803880163},{"date":"2024-03-01","current":29.282245,"twenty":40.169713,"median":56.86082,"eighty":89.975454,"marketCap":3706370818},{"date":"2024-03-08","current":31.196143,"twenty":39.686358,"median":56.779913,"eighty":89.650338,"marketCap":3948620596},{"date":"2024-03-15","current":30.333484,"twenty":39.199647,"median":56.623635,"eighty":89.309009,"marketCap":3839430445},{"date":"2024-03-22","current":32.215284,"twenty":38.802962,"median":56.576565,"eighty":89.042645,"marketCap":4077617333},{"date":"2024-03-28","current":33.739983,"twenty":38.68383,"median":56.517971,"eighty":88.628965,"marketCap":4270604578},{"date":"2024-04-05","current":34.060972,"twenty":38.430798,"median":56.447391,"eighty":88.026299,"marketCap":4311233472},{"date":"2024-04-12","current":34.714988,"twenty":38.170539,"median":56.213034,"eighty":87.780769,"marketCap":4394014842},{"date":"2024-04-19","current":33.487204,"twenty":37.914008,"median":56.109705,"eighty":87.462688,"marketCap":4238609324},{"date":"2024-04-26","current":35.172397,"twenty":37.610343,"median":55.996257,"eighty":87.410344,"marketCap":4451911016},{"date":"2024-05-03","current":37.447409,"twenty":37.448115,"median":55.925691,"eighty":87.031236,"marketCap":4739868299},{"date":"2024-05-10","current":40.004036,"twenty":37.42173,"median":55.823822,"eighty":86.74189,"marketCap":4702794434},{"date":"2024-05-17","current":40.954456,"twenty":37.42173,"median":55.726494,"eighty":86.304612,"marketCap":4814523891},{"date":"2024-05-24","current":38.334996,"twenty":37.42173,"median":55.579945,"eighty":86.083348,"marketCap":4506585418},{"date":"2024-05-31","current":36.609402,"twenty":37.413918,"median":55.43486,"eighty":85.929862,"marketCap":4303728065},{"date":"2024-06-07","current":37.873064,"twenty":37.403047,"median":55.250346,"eighty":85.523848,"marketCap":4452281703},{"date":"2024-06-14","current":37.296603,"twenty":37.244592,"median":55.138245,"eighty":85.094818,"marketCap":4384514082},{"date":"2024-06-21","current":37.058217,"twenty":37.126478,"median":55.022209,"eighty":84.728755,"marketCap":4356489879},{"date":"2024-06-28","current":36.052661,"twenty":37.09896,"median":54.946314,"eighty":83.535921,"marketCap":4238278691},{"date":"2024-07-05","current":36.464419,"twenty":37.043719,"median":54.885353,"eighty":82.319567,"marketCap":4286684134},{"date":"2024-07-12","current":38.791935,"twenty":37.017445,"median":54.609,"eighty":81.867773,"marketCap":4560302271},{"date":"2024-07-15","current":39.260039,"twenty":37.017445,"median":54.589123,"eighty":81.773605,"marketCap":4615331616},{"date":"2024-08-02","current":39.064995,"twenty":36.955248,"median":54.288688,"eighty":80.360332,"marketCap":4592402722},{"date":"2024-08-09","current":34.046029,"twenty":36.92102,"median":54.107954,"eighty":79.911493,"marketCap":3911514209},{"date":"2024-08-16","current":32.959122,"twenty":36.827919,"median":53.974996,"eighty":79.219819,"marketCap":3786640538},{"date":"2024-08-23","current":33.631757,"twenty":36.777806,"median":53.857029,"eighty":78.263641,"marketCap":3863918917},{"date":"2024-08-30","current":33.578302,"twenty":36.705542,"median":53.663055,"eighty":77.612662,"marketCap":3857777588},{"date":"2024-09-06","current":33.221939,"twenty":36.5432,"median":53.423229,"eighty":77.092502,"marketCap":3816835401},{"date":"2024-09-13","current":32.633941,"twenty":36.479103,"median":53.275733,"eighty":76.801829,"marketCap":3749280792},{"date":"2024-09-20","current":33.444666,"twenty":36.348592,"median":52.83765,"eighty":76.249976,"marketCap":3842424268},{"date":"2024-09-27","current":34.099483,"twenty":36.143985,"median":52.576392,"eighty":75.985907,"marketCap":3917655537},{"date":"2024-10-04","current":34.781028,"twenty":35.815644,"median":52.005614,"eighty":75.653859,"marketCap":3995957470},{"date":"2024-10-11","current":33.16403,"twenty":35.398884,"median":51.644579,"eighty":75.347255,"marketCap":3810182296},{"date":"2024-10-18","current":33.827757,"twenty":35.286388,"median":51.321786,"eighty":74.99485,"marketCap":3886437119},{"date":"2024-10-25","current":33.769848,"twenty":35.073467,"median":50.961335,"eighty":74.557795,"marketCap":3879784014},{"date":"2024-10-31","current":32.081578,"twenty":34.946551,"median":50.677905,"eighty":73.643703,"marketCap":3685820402},{"date":"2024-11-08","current":35.100579,"twenty":34.791083,"median":50.174897,"eighty":72.654053,"marketCap":4345872942},{"date":"2024-11-15","current":36.812407,"twenty":34.791083,"median":50.02786,"eighty":72.052383,"marketCap":4557817745},{"date":"2024-11-22","current":34.654368,"twenty":34.70383,"median":49.822008,"eighty":71.813687,"marketCap":4290626666},{"date":"2024-11-29","current":35.481887,"twenty":34.699053,"median":49.663186,"eighty":71.167911,"marketCap":4393083395},{"date":"2024-12-06","current":32.723492,"twenty":34.589092,"median":49.471895,"eighty":70.134049,"marketCap":4051560964},{"date":"2024-12-13","current":33.384695,"twenty":34.425584,"median":49.145638,"eighty":69.703258,"marketCap":4133425900},{"date":"2024-12-20","current":31.194205,"twenty":34.307596,"median":48.886853,"eighty":69.013231,"marketCap":3862216910},{"date":"2024-12-27","current":31.985215,"twenty":34.216342,"median":48.780986,"eighty":68.150231,"marketCap":3960153489},{"date":"2025-01-03","current":31.802675,"twenty":34.159174,"median":48.421341,"eighty":67.685601,"marketCap":3937552740},{"date":"2025-01-10","current":31.680981,"twenty":34.09592,"median":48.051683,"eighty":66.243612,"marketCap":3922485574},{"date":"2025-01-17","current":29.827177,"twenty":34.062068,"median":47.691624,"eighty":65.473912,"marketCap":3692962411},{"date":"2025-01-24","current":29.555394,"twenty":34.038606,"median":47.505878,"eighty":65.235863,"marketCap":3659312406},{"date":"2025-01-31","current":28.180253,"twenty":33.968145,"median":47.135606,"eighty":64.762279,"marketCap":3489053429},{"date":"2025-02-07","current":24.323243,"twenty":33.900182,"median":47.085636,"eighty":64.253801,"marketCap":3163602642},{"date":"2025-02-14","current":24.059445,"twenty":33.848111,"median":46.893327,"eighty":63.64383,"marketCap":3129291757},{"date":"2025-02-21","current":24.507494,"twenty":33.805614,"median":46.748088,"eighty":63.36814,"marketCap":3187567217},{"date":"2025-02-28","current":24.940093,"twenty":33.751655,"median":46.4766,"eighty":63.305096,"marketCap":3243833179},{"date":"2025-03-07","current":25.955928,"twenty":33.698834,"median":46.303836,"eighty":62.823315,"marketCap":3375957715},{"date":"2025-03-14","current":25.465391,"twenty":33.671773,"median":46.104914,"eighty":62.370223,"marketCap":3312156133},{"date":"2025-03-21","current":24.812631,"twenty":33.631757,"median":45.899062,"eighty":62.370223,"marketCap":3227254815},{"date":"2025-03-28","current":24.801043,"twenty":33.568866,"median":45.463832,"eighty":62.195899,"marketCap":3225747691},{"date":"2025-04-04","current":24.032408,"twenty":33.538212,"median":45.269432,"eighty":61.915464,"marketCap":3125775134},{"date":"2025-04-11","current":22.892974,"twenty":33.466383,"median":44.987585,"eighty":61.454392,"marketCap":2977574609},{"date":"2025-04-17","current":21.973701,"twenty":33.444666,"median":44.72681,"eighty":61.359919,"marketCap":2858009440},{"date":"2025-04-25","current":23.916533,"twenty":33.40903,"median":44.409226,"eighty":61.030153,"marketCap":3110703894},{"date":"2025-05-02","current":24.32982,"twenty":33.384695,"median":44.268479,"eighty":60.816466,"marketCap":3164457983},{"date":"2025-05-09","current":20.376136,"twenty":33.333303,"median":43.94712,"eighty":60.601496,"marketCap":3416650062},{"date":"2025-05-16","current":20.786595,"twenty":33.275509,"median":43.647294,"eighty":60.274332,"marketCap":3485475391},{"date":"2025-05-23","current":18.953642,"twenty":33.212021,"median":43.594152,"eighty":59.995745,"marketCap":3178127655},{"date":"2025-05-30","current":19.434931,"twenty":33.136862,"median":43.372889,"eighty":59.590266,"marketCap":3258829808},{"date":"2025-06-06","current":20.168325,"twenty":32.994758,"median":43.019921,"eighty":59.300599,"marketCap":3381804518},{"date":"2025-06-13","current":20.445148,"twenty":32.935122,"median":42.794357,"eighty":59.05806,"marketCap":3428222030},{"date":"2025-06-20","current":20.072689,"twenty":32.903454,"median":42.519444,"eighty":59.049702,"marketCap":3365768433},{"date":"2025-06-27","current":21.422138,"twenty":32.826351,"median":42.358765,"eighty":59.049702,"marketCap":3592042617},{"date":"2025-07-03","current":22.023803,"twenty":32.763412,"median":42.270964,"eighty":58.94778,"marketCap":3692929196},{"date":"2025-07-11","current":22.396262,"twenty":32.712177,"median":41.885191,"eighty":58.897162,"marketCap":3755382792},{"date":"2025-07-18","current":21.043948,"twenty":32.632287,"median":41.685812,"eighty":58.848934,"marketCap":3528628196},{"date":"2025-07-25","current":21.276019,"twenty":32.589701,"median":41.358335,"eighty":58.426416,"marketCap":3567541591},{"date":"2025-08-01","current":21.212987,"twenty":32.472243,"median":41.070887,"eighty":58.27739,"marketCap":3556972521},{"date":"2025-08-08","current":16.408412,"twenty":32.409946,"median":40.980992,"eighty":58.27739,"marketCap":2680100751},{"date":"2025-08-15","current":15.435056,"twenty":32.344141,"median":40.890107,"eighty":58.27739,"marketCap":2521115806},{"date":"2025-08-22","current":15.921734,"twenty":32.211263,"median":40.754606,"eighty":58.27739,"marketCap":2600608278},{"date":"2025-08-29","current":16.027918,"twenty":32.134827,"median":40.594873,"eighty":58.27739,"marketCap":2617952091},{"date":"2025-09-05","current":15.95123,"twenty":32.079623,"median":40.522806,"eighty":58.27739,"marketCap":2605426004},{"date":"2025-09-12","current":15.774256,"twenty":31.977432,"median":40.367395,"eighty":58.27739,"marketCap":2576519650},{"date":"2025-09-19","current":15.087008,"twenty":31.856603,"median":40.217505,"eighty":58.27739,"marketCap":2464266644},{"date":"2025-09-26","current":14.060561,"twenty":31.724738,"median":40.042158,"eighty":58.27739,"marketCap":2296609793},{"date":"2025-10-03","current":14.423357,"twenty":31.641523,"median":39.354745,"eighty":58.27739,"marketCap":2355867818},{"date":"2025-10-10","current":14.792052,"twenty":31.524009,"median":39.084022,"eighty":58.27739,"marketCap":2416089388},{"date":"2025-10-17","current":14.679969,"twenty":31.400177,"median":38.952863,"eighty":58.27739,"marketCap":2397782031},{"date":"2025-10-24","current":15.145999,"twenty":31.175545,"median":38.703439,"eighty":58.27739,"marketCap":2473902095},{"date":"2025-10-31","current":14.744859,"twenty":31.002719,"median":38.556255,"eighty":58.27739,"marketCap":2408381027},{"date":"2025-11-07","current":18.677669,"twenty":30.681757,"median":38.355513,"eighty":58.27739,"marketCap":3141397087},{"date":"2025-11-14","current":20.570205,"twenty":30.436951,"median":38.210341,"eighty":58.27739,"marketCap":3459702857},{"date":"2025-11-21","current":20.906966,"twenty":30.050212,"median":38.028724,"eighty":58.27739,"marketCap":3516342560},{"date":"2025-11-28","current":22.640863,"twenty":29.969216,"median":37.896633,"eighty":58.27739,"marketCap":3807966817},{"date":"2025-12-05","current":23.325516,"twenty":29.797432,"median":37.799918,"eighty":58.27739,"marketCap":3923118610},{"date":"2025-12-12","current":23.503638,"twenty":29.475641,"median":37.58676,"eighty":58.27739,"marketCap":3953076800},{"date":"2025-12-19","current":22.237308,"twenty":29.010488,"median":37.449174,"eighty":58.27739,"marketCap":3740092792},{"date":"2025-12-26","current":22.267922,"twenty":28.82644,"median":37.406993,"eighty":58.27739,"marketCap":3745241856},{"date":"2026-01-02","current":22.306886,"twenty":28.645081,"median":37.32911,"eighty":58.27739,"marketCap":3751795210},{"date":"2026-01-09","current":23.389529,"twenty":28.037331,"median":37.212455,"eighty":58.046979,"marketCap":3933884834},{"date":"2026-01-16","current":20.595254,"twenty":26.82467,"median":37.10156,"eighty":57.831411,"marketCap":3463915728},{"date":"2026-01-23","current":19.487563,"twenty":26.554284,"median":37.063484,"eighty":57.598283,"marketCap":3277613233},{"date":"2026-01-30","current":18.357607,"twenty":26.158475,"median":36.994993,"eighty":57.554081,"marketCap":3087565965},{"date":"2026-02-06","current":17.223188,"twenty":25.487021,"median":36.865307,"eighty":57.309926,"marketCap":3021567177},{"date":"2026-02-13","current":15.268295,"twenty":25.290807,"median":36.812645,"eighty":56.950229,"marketCap":2678608614},{"date":"2026-02-20","current":16.070914,"twenty":25.0691,"median":36.777806,"eighty":56.728357,"marketCap":2819416804},{"date":"2026-02-27","current":16.486792,"twenty":24.816493,"median":36.703641,"eighty":56.554757,"marketCap":2892376824},{"date":"2026-03-06","current":17.013924,"twenty":24.732291,"median":36.525858,"eighty":56.498586,"marketCap":2984854810},{"date":"2026-03-13","current":15.758343,"twenty":24.555389,"median":36.464419,"eighty":56.498586,"marketCap":2764580611},{"date":"2026-03-20","current":15.602057,"twenty":24.34835,"median":36.312545,"eighty":56.425004,"marketCap":2737162515},{"date":"2026-03-27","current":14.706727,"twenty":24.310168,"median":36.137833,"eighty":56.425004,"marketCap":2580089352},{"date":"2026-04-02","current":14.897448,"twenty":24.126653,"median":35.870547,"eighty":56.425004,"marketCap":2613548724},{"date":"2026-04-10","current":15.47491,"twenty":23.751991,"median":35.747799,"eighty":56.425004,"marketCap":2714856267},{"date":"2026-04-17","current":15.922575,"twenty":23.415614,"median":35.47792,"eighty":56.425004,"marketCap":2793392848},{"date":"2026-04-24","current":15.792778,"twenty":23.292299,"median":35.47792,"eighty":56.425004,"marketCap":2770621887},{"date":"2026-05-01","current":15.917277,"twenty":23.069468,"median":35.47792,"eighty":56.425004,"marketCap":2792463421},{"date":"2026-05-08","current":25.965463,"twenty":22.884856,"median":35.47792,"eighty":56.425004,"marketCap":2526647299},{"date":"2026-05-15","current":27.27878,"twenty":22.884856,"median":35.47792,"eighty":56.425004,"marketCap":2654443512},{"date":"2026-05-22","current":28.927983,"twenty":22.884856,"median":35.47792,"eighty":56.425004,"marketCap":2814924187},{"date":"2026-05-29","current":31.309848,"twenty":22.876737,"median":35.424832,"eighty":56.44471,"marketCap":3046698700},{"date":"2026-06-05","current":32.622209,"twenty":22.884856,"median":35.310518,"eighty":56.425004,"marketCap":3174401912},{"date":"2026-06-12","current":37.287862,"twenty":22.884856,"median":35.233869,"eighty":56.425004,"marketCap":3628407282},{"date":"2026-06-18","current":33.967262,"twenty":22.884856,"median":35.141576,"eighty":56.425004,"marketCap":3305286343},{"date":"2026-06-26","current":36.25105,"twenty":22.876737,"median":34.980217,"eighty":56.44471,"marketCap":3527517200},{"date":"2026-07-02","current":34.957371,"twenty":22.876737,"median":34.971382,"eighty":56.44471,"marketCap":3401631827},{"date":"2026-07-10","current":35.027426,"twenty":22.876737,"median":34.957371,"eighty":56.44471,"marketCap":3408448725},{"date":"2026-07-17","current":36.662039,"twenty":22.876737,"median":34.956482,"eighty":56.44471,"marketCap":3567509665},{"date":"2026-07-24","current":36.148303,"twenty":22.876737,"median":34.956482,"eighty":56.44471,"marketCap":3517519084},{"date":"2026-07-31","current":39.613683,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":3854728278},{"date":"2026-08-07","current":40.173225,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":3868159276},{"date":"2026-08-14","current":42.705905,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4112023469},{"date":"2026-08-21","current":51.135572,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4923690859},{"date":"2026-08-24","current":51.409631,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4950079148}],"updateTime":1787686913542},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HAE\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622007554","title":"Here's one reason why experts think the CSL share price can rise 65%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007554","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007554?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:00","pubTimestamp":1774472400,"startTime":"0","endTime":"0","summary":"The CSL Ltd  share price has taken a dive over the last several months. As the chart below shows, it has fallen almost 50% from August 2025. But, experts think there's a chance that the ASX healthcare share could recover a lot of the lost ground.The global biotech business provides a number of healthcare products, including blood plasma-related treatments and vaccines.UBS recently released a note that outlined one of the reasons why investors can be excited by the business.The broker said that there has been a rapid uptake of CSL's Andembry since the launch in mid-2025, with more than 1,000 patients on the therapy. UBS estimates this is around 15% of patients on prophylactic treatment across the major markets where it has been approved.At a US price of around $400,000, the broker said this early momentum should underpin \"strong second-half FY26 sales and extend into FY27\".UBS suggests that its hereditary angioedema  forecasts may prove conservative, as it has allowed for competitive pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/26/heres-one-reason-why-experts-think-the-csl-share-price-can-rise-65/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/26/heres-one-reason-why-experts-think-the-csl-share-price-can-rise-65/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4198","IE0034235071.USD","LU0205194284.USD","LU0106261612.USD","LU0012050646.USD","LU1863844665.USD","HAE","SGXZ23171101.USD","CSL","BK7501","SG9999004303.SGD","LU0205193047.USD","LU1829250122.USD","BK7067","LU3187612489.SGD","BK7511","LU1169590202.USD","UBS","BK4086","IE00B64QTZ34.USD","BK7508","LU1169589451.USD","CSL.AU","LU1863844749.USD","IE00BLDYK493.USD","BK4585","LU0728928796.USD","BK4534","IE0034390439.USD","BK4588","IE00B19Z6F94.USD","BK4118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622027088","title":"Press Release: KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622027088?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:00","pubTimestamp":1774436400,"startTime":"0","endTime":"0","summary":"$49.1 million global net product revenue of EKTERLY  for the eight months ended December 31, 2025. 1,702 patient start forms received in the US from launch through end of February, reflecting continued rapid adoption of first and only oral on-demand treatment for hereditary angioedema . EKTERLY launched in Japan by partner Kaken Pharmaceutical Co., LTD. Company to host conference call today at 8:30am ET. KalVista Pharmaceuticals, Inc. , today reported financial results for the eight months ended December 31, 2025, and provided a corporate update. As previously announced, the Company changed its fiscal year from ending April 30 of each year to ending December 31 of each year. There was an eight-month transition period from May 1, 2025 to December 31, 2025 and these results are presented within the condensed consolidated financial statements.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","R","BK4225","LU0205194284.USD","LU0106261612.USD","LU0012050646.USD","BK4139","HAE","BK4232","LU0205193047.USD","BK4022","LU1169590202.USD","BK4203","IE00B64QTZ34.USD","LU1169589451.USD","IE00BLDYK493.USD","NHI","KALV","IE0034390439.USD","IE00B19Z6F94.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620738370","title":"Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology","url":"https://stock-news.laohu8.com/highlight/detail?id=2620738370","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620738370?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:50","pubTimestamp":1774003800,"startTime":"0","endTime":"0","summary":"Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAE ZUG, Switzerland, March  20, 2026 (GLOBE NEWSWIRE","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/20/3259646/0/en/Evidence-of-Efficacy-and-Safety-of-Deucrictibant-for-Prophylaxis-and-On-Demand-Treatment-of-Hereditary-Angioedema-Attacks-Published-Back-to-Back-in-The-Lancet-Haematology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0205194284.USD","BK4198","LU0012050646.USD","LU1169590202.USD","LU0106261612.USD","IE00B19Z6F94.USD","LU1169589451.USD","IE00B64QTZ34.USD","IE00BLDYK493.USD","IE0034390439.USD","HAE","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620643446","title":"Is New HAE Patient-Reported Outcome Study Altering The Investment Case For Pharvaris’ Deucrictibant (PHVS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620643446","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620643446?lang=en_us&edition=fundamental","pubTime":"2026-03-17 13:14","pubTimestamp":1773724454,"startTime":"0","endTime":"0","summary":"Pharvaris recently reported that a company-sponsored real-world, mixed methods study on patient experiences during acute hereditary angioedema (HAE) attacks and related clinical endpoints has been published in Clinical Reviews in Allergy & Immunology, supporting the use of several patient-reported outcome (PRO) tools in ongoing and future deucrictibant trials.\nThe study’s finding that patients view even small early improvements, captured by the End of Progression™ endpoint, as meaningfully...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/is-new-hae-patient-reported-outcome-study-altering-the-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/is-new-hae-patient-reported-outcome-study-altering-the-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PHVS","LU0205194284.USD","IE00BLDYK493.USD","IE00B19Z6F94.USD","PRO","HAE","LU1169590202.USD","PRO.AU","IE0034390439.USD","BK4023","BK4007","LU0205193047.USD","BK7024","LU0012050646.USD","LU0106261612.USD","BK4198","IE00B64QTZ34.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619511152","title":"Takeda’s New South Korea HAE Study Aims to Cement Takhzyro’s Real World Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=2619511152","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619511152?lang=en_us&edition=fundamental","pubTime":"2026-03-14 00:32","pubTimestamp":1773419521,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. This post marketing study from Takeda tracks real world u...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-new-south-korea-hae-study-aims-to-cement-takhzyros-real-world-edge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-new-south-korea-hae-study-aims-to-cement-takhzyros-real-world-edge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0205194284.USD","IE00BLDYK493.USD","IE00B19Z6F94.USD","HAE","LU1169590202.USD","IE0034390439.USD","LU0205193047.USD","LU0012050646.USD","LU0106261612.USD","BK4198","IE00B64QTZ34.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619111631","title":"Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2619111631","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619111631?lang=en_us&edition=fundamental","pubTime":"2026-03-14 00:31","pubTimestamp":1773419507,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is launching a real‑world study in Egypt on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-explorhae-hae-study-in-egypt-real‑world-data-with-long‑term-investor-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-explorhae-hae-study-in-egypt-real‑world-data-with-long‑term-investor-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64QTZ34.USD","IE00BLDYK493.USD","LU0012050646.USD","LU1169589451.USD","BK4007","HAE","LU0106261612.USD","IE0034390439.USD","TAK","LU0205194284.USD","BK4198","LU0205193047.USD","IE00B19Z6F94.USD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618830136","title":"Early Outperformance and Expanding On‑Demand HAE Opportunity Justify Buy Rating on KalVista","url":"https://stock-news.laohu8.com/highlight/detail?id=2618830136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618830136?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:55","pubTimestamp":1773312934,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein maintained a Buy rating on KalVista Pharmaceuticals today and set a price target of $37.00. Andrew Fein has giv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/early-outperformance-and-expanding-on‑demand-hae-opportunity-justify-buy-rating-on-kalvista-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/early-outperformance-and-expanding-on‑demand-hae-opportunity-justify-buy-rating-on-kalvista-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618929216","title":"Haemonetics Is Maintained at Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2618929216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618929216?lang=en_us&edition=fundamental","pubTime":"2026-03-11 23:49","pubTimestamp":1773244140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HAE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2026 11:49 ET (15:49 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618525949","title":"Pharvaris reports results from study of patient experience during HAE attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2618525949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618525949?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:55","pubTimestamp":1773226559,"startTime":"0","endTime":"0","summary":"Pharvaris (PHVS) announced that results from a Pharvaris-sponsored non-interventional, mixed methods, real-world study assessing the patient experi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-reports-results-from-study-of-patient-experience-during-hae-attacks-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-reports-results-from-study-of-patient-experience-during-hae-attacks-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0012050646.USD","HAE","LU0106261612.USD","IE00B19Z6F94.USD","IE00BLDYK493.USD","LU1169589451.USD","LU1169590202.USD","LU0205194284.USD","BK4007","PHVS","LU0205193047.USD","IE00B64QTZ34.USD","BK4198","IE0034390439.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618499679","title":"Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology","url":"https://stock-news.laohu8.com/highlight/detail?id=2618499679","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618499679?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:50","pubTimestamp":1773226200,"startTime":"0","endTime":"0","summary":"Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253609/0/en/Validation-of-Patient-Reported-Outcomes-in-the-On-Demand-Treatment-of-Hereditary-Angioedema-Attacks-Published-in-Clinical-Reviews-in-Allergy-Immunology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODT","HAE","BK4023","IE00B64QTZ34.USD","LU0205193047.USD","PRO","IE00BLDYK493.USD","LU0205194284.USD","IE00B19Z6F94.USD","LU0106261612.USD","LU1169589451.USD","IE0034390439.USD","BK4198","LU1169590202.USD","LU0012050646.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618948211","title":"Haemonetics price target lowered to $70 from $75 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2618948211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618948211?lang=en_us&edition=fundamental","pubTime":"2026-03-11 17:26","pubTimestamp":1773221179,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch lowered the firm’s price target on Haemonetics (HAE) to $70 from $75 and keeps a Neutral rating on the shares. The firm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/haemonetics-price-target-lowered-to-70-from-75-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/haemonetics-price-target-lowered-to-70-from-75-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618916466","title":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2618916466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618916466?lang=en_us&edition=fundamental","pubTime":"2026-03-11 15:10","pubTimestamp":1773213002,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, OracleMarch 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wednesday, includin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ0GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPRT","CNC","HLT","HWM","ABM","CASY","HOG","DXCM","HAE","HIYY","MET","ORCX","T","CLYM","EXPE","ORCL","ALMS","BLND","DBI","ELV","SJM","HMYY","ADC","AVXX","ORCU","HAS","AVAV","AVR","FICO","BSX","REGN","UEC","RNA","BKNG","BKNU","ORCS","HIMY","H","CNCG","GEHC","HIMS","NKE","HIMZ","CRBG","PGNY","APYX","BMRN","ABT","CDW","CHH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2617596755","title":"Haemonetics Wins FDA Nod For Persona PLUS Plasma Growth Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2617596755","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617596755?lang=en_us&edition=fundamental","pubTime":"2026-03-05 10:36","pubTimestamp":1772678174,"startTime":"0","endTime":"0","summary":"Haemonetics (NYSE:HAE) has received FDA 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS technology.\nThe clearance covers the company's next generation plasma collection platform, Persona PLUS, which is designed to improve plasma collection per donation.\nThis regulatory milestone marks an important step in advancing Haemonetics' plasma collection offerings within the U.S. market.\n\nHaemonetics focuses on blood and plasma collection technologies, so any regulatory...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/haemonetics-wins-fda-nod-for-persona-plus-plasma-growth-oppo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/haemonetics-wins-fda-nod-for-persona-plus-plasma-growth-oppo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z6F94.USD","IE00B64QTZ34.USD","LU1169589451.USD","IE00BLDYK493.USD","PLUS","HAE","BK4140","BK4198","LU1169590202.USD","LU0106261612.USD","IE0034390439.USD","LU0205193047.USD","LU0012050646.USD","LU0205194284.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616340527","title":"BRIEF-Haemonetics Corp - Repays Outstanding 0.00% Convertible Senior Notes - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616340527","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616340527?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:54","pubTimestamp":1772542461,"startTime":"0","endTime":"0","summary":"BRIEF-Haemonetics Corp - Repays Outstanding 0.00% Convertible Senior Notes - SEC FilingMarch 3  - SEC Filing:HAEMONETICS CORP - REPAYS OUTSTANDING 0.00% CONVERTIBLE SENIOR NOTES - SEC FILINGHAEMONETICS CORP - PAYS $300 MILLION FOR OUTSTANDING NOTES - SEC FILINGHAEMONETICS CORP - REPAYMENT FUNDED WITH CASH AND CREDIT FACILITY BORROWINGS - SEC FILINGSource text: [ID:n0000313143-26-000017]Further company coverage: HAE.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR15O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE","LU1169590202.USD","IE0034390439.USD","LU0205193047.USD","BK4198","LU0106261612.USD","IE00B19Z6F94.USD","LU0205194284.USD","IE00B64QTZ34.USD","IE00BLDYK493.USD","LU0012050646.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616349739","title":"Haemonetics Corp - Repayment Funded With Cash and Credit Facility Borrowings - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616349739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616349739?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:10","pubTimestamp":1772536227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR15O:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0205193047.USD","BK4198","IE00B19Z6F94.USD","LU0106261612.USD","IE00B64QTZ34.USD","IE0034390439.USD","HAE","LU1169589451.USD","LU0012050646.USD","IE00BLDYK493.USD","LU1169590202.USD","LU0205194284.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616349735","title":"Haemonetics Corp - Pays $300 Mln for Outstanding Notes - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616349735","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616349735?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:10","pubTimestamp":1772536227,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR15O:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0205194284.USD","LU0205193047.USD","IE0034390439.USD","LU1169590202.USD","LU1169589451.USD","BK4198","LU0106261612.USD","IE00B19Z6F94.USD","LU0012050646.USD","HAE","IE00BLDYK493.USD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616492813","title":"Haemonetics Repays $300 Million Convertible Notes at Maturity","url":"https://stock-news.laohu8.com/highlight/detail?id=2616492813","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616492813?lang=en_us&edition=fundamental","pubTime":"2026-03-03 19:09","pubTimestamp":1772536184,"startTime":"0","endTime":"0","summary":"Haemonetics Corporation said it repaid in full at maturity its 0.00% Convertible Senior Notes due 2026, paying $300 million in cash for the outstanding principal. The repayment was funded with cash on hand and borrowings under its revolving credit facility, and no noteholders exercised conversion rights before maturity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL28yC4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z6F94.USD","IE00B64QTZ34.USD","HAE","LU0205194284.USD","IE00BLDYK493.USD","LU1169590202.USD","IE0034390439.USD","LU0106261612.USD","LU1169589451.USD","BK4198","LU0012050646.USD","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616346736","title":"Assessing Haemonetics (HAE) Valuation After FDA Clearance Of NexSys PCS Persona PLUS System","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346736","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616346736?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:29","pubTimestamp":1772533798,"startTime":"0","endTime":"0","summary":"Haemonetics (HAE) is back in focus after receiving FDA 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS, a next-generation platform designed to tailor plasma collection volumes to individual donors.\nSee our latest analysis for Haemonetics.\nDespite the FDA clearance and recent conference appearance, Haemonetics’ share price, last closing at $63.88, shows mixed momentum. The stock has a 4.23% 7 day share price return, but a 20.13% decline year to date and a 20.93%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/assessing-haemonetics-hae-valuation-after-fda-clearance-of-n","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/assessing-haemonetics-hae-valuation-after-fda-clearance-of-n","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0012050646.USD","LU1169589451.USD","PCS","LU0205193047.USD","IE00BLDYK493.USD","PLUS","IE00B19Z6F94.USD","IE0034390439.USD","LU1169590202.USD","BK4198","LU0205194284.USD","HAE","BK4140","IE00B64QTZ34.USD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616331432","title":"Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331432","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331432?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:50","pubTimestamp":1772452200,"startTime":"0","endTime":"0","summary":"RAPIDe-3 met the primary and all 11 secondary efficacy endpoints with high statistical significance with deucrictibant achieving onset of symptom relief in 1.28 hours and complete symptom resolution i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/02/3247196/0/en/Deucrictibant-Data-Supporting-Potentially-Differentiated-Profile-for-the-On-Demand-and-Prophylactic-Treatment-of-Bradykinin-Mediated-Angioedema-Presented-at-AAAAI-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","BK4198","IE00B64QTZ34.USD","BK4216","LU0012050646.USD","AMRA","IE00BLDYK493.USD","LU0205194284.USD","LU1169590202.USD","LU0205193047.USD","LU0106261612.USD","IE0034390439.USD","IE00B19Z6F94.USD","HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614104431","title":"BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2614104431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614104431?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:57","pubTimestamp":1772110621,"startTime":"0","endTime":"0","summary":"An update from BioCryst ( ($BCRX) ) is now available. BioCryst Pharmaceuticals, Inc. is a global biotechnology company focused on developing and co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biocryst-boosts-hae-franchise-with-astria-acquisition-guidance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biocryst-boosts-hae-franchise-with-astria-acquisition-guidance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","LU1169589451.USD","IE00B64QTZ34.USD","IE00B19Z6F94.USD","IE0034390439.USD","LU0205194284.USD","LU1169590202.USD","HAE","LU0012050646.USD","LU0106261612.USD","LU0205193047.USD","IE00BLDYK493.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":141,"code":"91000000","status":"200"}]}}